After 12 months of immunotherapy, in the group GCA + VA, median CRP was lower in the TCZ-group (median CRP 0.06 mg/dL) than in the non-TCZ group (median CRP 2.6 mg/dL), which can be explained by IL 6-receptor blockade affecting CRP and ESR. This evidence concerns the gene CRP and temporal arteritis.